Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8911993 Compositions for treatment of cancer

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
July 10, 2013
0
Date of Patent
December 16, 2014
0
Patent Application Number
13938923
0
Patent Citations Received
‌
US Patent 12128069 Treatment of cancer using chimeric antigen receptor and protein kinase a blocker
0
‌
US Patent 11999794 Human mesothelin chimeric antigen receptors and uses thereof
0
‌
US Patent 12006356 Anti-CCT5 binding molecules and chimeric antigen receptors comprising the same
0
‌
US Patent 12018080 Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway
0
‌
US Patent 12024719 Transgenic macrophages, chimeric antigen receptors, and associated methods
0
‌
US Patent 12076378 Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors
0
‌
US Patent 12076375 Treating and preventing
0
‌
US Patent 11661459 Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
0
‌
US Patent 11667691 Treatment of cancer using chimeric CD3 receptor proteins
0
‌
US Patent 11680103 Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy
0
•••
Patent Inventor Names
Michael C. Milone
0
Bruce L. Levine
0
Carl H. June
0
David L. Porter
0
Michael D. Kalos
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8911993
0
Patent Primary Examiner
‌
Michael Burkhart
0

Find more entities like US Patent 8911993 Compositions for treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo